|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
2U10CA014958-36
|
$127,404
|
$5,096
|
SPARANO, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$4,612
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Proteosome Inhibition Therapy for Hematologic Malignancy
|
5K23CA113775-05
|
$134,015
|
$67,008
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
3P01CA084512-07S2
|
$200,000
|
$40,000
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-26S1
|
$487,529
|
$4,875
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-12
|
$104,956
|
$4,198
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Heat shock proteins in signaling and cancer
|
5R01CA081244-12
|
$355,597
|
$106,679
|
SHERMAN, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
|
5R01CA132778-02
|
$273,159
|
$273,159
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Energy Balance, IGF Dysregulation and Multiple Myeloma
|
5K07CA115687-05
|
$140,130
|
$140,130
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
1U10CA142559-01
|
$188,304
|
$11,298
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women
|
5R03CA135687-02
|
$72,500
|
$21,750
|
Chang, Ellen
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-27
|
$821,099
|
$16,422
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Eastern Cooperative Oncology Group Studies
|
2U10CA014548-36
|
$420,754
|
$16,830
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-21
|
$209,928
|
$4,199
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$12,027
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
2U10CA046368-23
|
$431,902
|
$25,914
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-15
|
$959,745
|
$19,195
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Multiple Myeloma and Cancer Therapies via Largazole Analogs
|
1R01CA152314-01
|
$338,173
|
$338,173
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Determinants and risks of use and overuse of expensive oncology drugs
|
5R01CA134964-03
|
$260,820
|
$52,164
|
HERSHMAN, DAWN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program (Columbus CCOP)
|
2U10CA035261-27
|
$750,000
|
$15,000
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
2P01CA078378-11A2
|
$2,056,275
|
$2,056,275
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
SPORE in Myeloma
|
5P50CA100707-08
|
$2,300,000
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-18
|
$287,403
|
$287,403
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$929
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Selective Inhibition of HDAC6 in Cancer Therapy
|
5K08CA128972-03
|
$139,320
|
$139,320
|
BRADNER, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
|
1R01CA151391-01
|
$350,957
|
$350,957
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INSTITUTE
|
|
CXCR4 regulation of tumor progression in Multiple Myeloma
|
5R01CA125690-03
|
$320,667
|
$320,667
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
|
5R01CA133799-03
|
$354,054
|
$354,054
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
2U10CA023318-34
|
$2,382,969
|
$95,319
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Differentiating Agents in Hematologic Malignancies
|
5R01CA042802-23
|
$333,828
|
$166,914
|
KUFE, DONALD
|
DANA-FARBER CANCER INSTITUTE
|
|
Homologous Recombination Mediates Genomic Instability and Progression in Myeloma
|
5R01CA124929-03
|
$354,825
|
$354,825
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INSTITUTE
|
|
MODIFICATIONS MATTER IN MCL1 TURNOVER AND CELL VIABILITY
|
5R01CA057359-18
|
$308,120
|
$154,060
|
Craig, Ruth
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S1
|
$100,000
|
$2,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S2
|
$87,459
|
$1,749
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S3
|
$100,000
|
$2,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-32
|
$3,290,263
|
$65,805
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Different active sites of the proteasome as drug targets in cancer
|
5R01CA124634-04
|
$273,429
|
$136,715
|
Kisselev, Alexei
|
DARTMOUTH COLLEGE
|
|
Dayton Clinical Oncology Program
|
5U10CA035090-28
|
$942,207
|
$9,422
|
Gross, Howard
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA045807-25
|
$1,350,000
|
$27,000
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Eastern Cooperative Group Chair's Office
|
2U10CA086802-12
|
$648,867
|
$25,955
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Eastern Cooperative Group Chair's Office
|
3U10CA086802-12S1
|
$1,499,758
|
$59,990
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
2U10CA035269-27
|
$727,154
|
$7,272
|
NIKCEVICH, DANIEL
|
DULUTH CLINIC, LTD.
|
|
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress
|
5R01CA127910-04
|
$321,625
|
$321,625
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Arsenic-induced apoptosis in myeloma
|
7R01CA129968-02
|
$387,826
|
$387,826
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-02S1
|
$49,963
|
$2,498
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-02S2
|
$115,904
|
$5,795
|
Curran, Walter
|
EMORY UNIVERSITY
|
Total relevant funding to Multiple Myeloma for this search: $48,458,021
|